Diabetes Self-Management Training CPT G0108 and G0109

 HCPCS/CPT Codes

• G0108 – DSMT, individual, per 30 minutes
• G0109 – DSMT, group (2 or more), per 30 minutes

Who Is Covered

Certain Medicare beneficiaries when all of the following are true:

• Diagnosed with diabetes
• Receive an order for DSMT from the physician or qualified NPP treating the Medicare beneficiary’s diabetes

Frequently Used ICD Codes

• E24.4 Alcohol-induced pseudo-Cushing's syndrome
• F10.10 Alcohol abuse, uncomplicated
• F10.120 Alcohol abuse with intoxication, uncomplicated
• F10.121 Alcohol abuse with intoxication delirium
• F10.129 Alcohol abuse with intoxication, unspecified
• F10.14 Alcohol abuse with alcohol-induced mood disorder
• F10.150 Alcohol abuse with alcohol-induced psychotic disorder with delusions
• F10.151 Alcohol abuse with alcohol-induced psychotic disorder with hallucinations
• F10.159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified
• F10.180 Alcohol abuse with alcohol-induced anxiety disorder
• F10.181 Alcohol abuse with alcohol-induced sexual dysfunction
• F10.182 Alcohol abuse with alcohol-induced sleep disorder
• F10.188 Alcohol abuse with other alcohol-induced disorder
• F10.19 Alcohol abuse with unspecified alcohol-induced disorder
• F10.20 Alcohol dependence, uncomplicated
• F10.21 Alcohol dependence, in remission
• F10.220 Alcohol dependence with intoxication, uncomplicated
• F10.221 Alcohol dependence with intoxication delirium
• F10.229 Alcohol dependence with intoxication, unspecified
• F10.230 Alcohol dependence with withdrawal, uncomplicated
• F10.231 Alcohol dependence with withdrawal delirium
• F10.232 Alcohol dependence with withdrawal with perceptual disturbance
• F10.239 Alcohol dependence with withdrawal, unspecified
• F10.24 Alcohol dependence with alcohol-induced mood disorder
• F10.250 Alcohol dependence with alcohol-induced psychotic disorder with delusions
• F10.251 Alcohol dependence with alcohol-induced psychotic disorder with hallucinations
• F10.259 Alcohol dependence with alcohol-induced psychotic disorder, unspecified
• F10.26 Alcohol dependence with alcohol-induced persisting amnestic disorder
• F10.27 Alcohol dependence with alcohol-induced persisting dementia
• F10.280 Alcohol dependence with alcohol-induced anxiety disorder
• F10.281 Alcohol dependence with alcohol-induced sexual dysfunction
• E08.00 Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
• E08.01 Diabetes mellitus due to underlying condition with hyperosmolarity with coma
• E08.10 Diabetes mellitus due to underlying condition with ketoacidosis without coma
• E08.11 Diabetes mellitus due to underlying condition with ketoacidosis with coma
• E08.21 Diabetes mellitus due to underlying condition with diabetic nephropathy
• E08.22 Diabetes mellitus due to underlying condition with diabetic chronic kidney disease
• E08.29 Diabetes mellitus due to underlying condition with other diabetic kidney complication
• E08.311 Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema
• E08.319 Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema
• E08.3211 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye
• E08.3212 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye
• E08.3213 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral
• E08.3219 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E08.3291 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye
• E08.3292 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, left eye
• E08.3293 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral
• E08.3299 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E08.3311 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye
• E08.3312 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye
• E08.3313 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
• E08.3319 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E08.3391 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, right eye
• E08.3392 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, left eye
• E08.3393 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
• E08.3399 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E08.3411 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, right eye
• E08.3412 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, left eye
• E08.3413 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, bilateral
• E08.3419 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E08.3491 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, right eye
• E08.3492 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, left eye
• E08.3493 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, bilateral
• E08.3499 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E08.3511 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eye
• E08.3512 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eye
• E08.3513 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateral
• E08.3519 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, unspecified eye
• E08.3521 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye
• E08.3522 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye
• E08.3523 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral
• E08.3529 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye
• E08.3531 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye
• E08.3532 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye
• E08.3533 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral
• E08.3539 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye
• E08.3541 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye
• E08.3542 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye
• E08.3543 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral
• E08.3549 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye
• E08.3551 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, right eye
• E08.3552 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, left eye
• E08.3553 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, bilateral
• E08.3559 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, unspecified eye
• E08.3591 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, right eye
• E08.3592 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, left eye
• E08.3593 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral
• E08.3599 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye
• E08.36 Diabetes mellitus due to underlying condition with diabetic cataract
• E08.37X1 Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, right eye
• E08.37X2 Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, left eye
• E08.37X3 Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, bilateral
• E08.37X9 Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, unspecified eye
• E08.39 Diabetes mellitus due to underlying condition with other diabetic ophthalmic complication
• E08.40 Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified
• E08.41 Diabetes mellitus due to underlying condition with diabetic mononeuropathy
• E08.42 Diabetes mellitus due to underlying condition with diabetic polyneuropathy
• E08.43 Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy
• E08.44 Diabetes mellitus due to underlying condition with diabetic amyotrophy
• E08.49 Diabetes mellitus due to underlying condition with other diabetic neurological complication
• E08.51 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene
• E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene
• E08.59 Diabetes mellitus due to underlying condition with other circulatory complications
• E08.610 Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy
• E08.618 Diabetes mellitus due to underlying condition with other diabetic arthropathy
• E08.620 Diabetes mellitus due to underlying condition with diabetic dermatitis
• E08.621 Diabetes mellitus due to underlying condition with foot ulcer
• E08.622 Diabetes mellitus due to underlying condition with other skin ulcer
• E08.628 Diabetes mellitus due to underlying condition with other skin complications
• E08.630 Diabetes mellitus due to underlying condition with periodontal disease
• E08.638 Diabetes mellitus due to underlying condition with other oral complications
• E08.641 Diabetes mellitus due to underlying condition with hypoglycemia with coma
• E08.649 Diabetes mellitus due to underlying condition with hypoglycemia without coma
• E08.65 Diabetes mellitus due to underlying condition with hyperglycemia
• E08.69 Diabetes mellitus due to underlying condition with other specified complication
• E08.8 Diabetes mellitus due to underlying condition with unspecified complications
• E08.9 Diabetes mellitus due to underlying condition without complications
• E09.00 Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
• E09.01 Drug or chemical induced diabetes mellitus with hyperosmolarity with coma
• E09.10 Drug or chemical induced diabetes mellitus with ketoacidosis without coma
• E09.11 Drug or chemical induced diabetes mellitus with ketoacidosis with coma
• E09.21 Drug or chemical induced diabetes mellitus with diabetic nephropathy
• E09.22 Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease
• E09.29 Drug or chemical induced diabetes mellitus with other diabetic kidney complication
• E09.311 Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema
• E09.319 Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy without macular edema
• E09.3211 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
• E09.3212 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
• E09.3213 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
• E09.3219 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E09.3291 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
• E09.3292 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
• E09.3293 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
• E09.3299 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E09.3311 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
• E09.3312 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
• E09.3313 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
• E09.3319 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E09.3391 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
• E09.3392 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
• E09.3393 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
• E09.3399 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E09.3411 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
• E09.3412 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
• E09.3413 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
• E09.3419 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E09.3491 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
• E09.3492 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
• E09.3493 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
• E09.3499 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E09.3511 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
• E09.3512 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
• E09.3513 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
• E09.3519 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye
• E09.3521 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye
• E09.3522 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye
• E09.3523 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral
• E09.3529 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye
• E09.3531 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye
• E09.3532 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye
• E09.3533 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral
• E09.3539 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye
• E09.3541 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye
• E09.3542 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye
• E09.3543 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral
• E09.3549 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye
• E09.3551 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, right eye
• E09.3552 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, left eye
• E09.3553 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral
• E09.3559 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye
• E09.3591 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
• E09.3592 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
• E09.3593 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
• E09.3599 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye
• E09.36 Drug or chemical induced diabetes mellitus with diabetic cataract
• E09.37X1 Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, right eye
• E09.37X2 Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, left eye
• E09.37X3 Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral
• E09.37X9 Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye
• E09.39 Drug or chemical induced diabetes mellitus with other diabetic ophthalmic complication
• E09.40 Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified
• E09.41 Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy
• E09.42 Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy
• E09.43 Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy
• E09.44 Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy
• E09.49 Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication
• E09.51 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene
• E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene
• E09.59 Drug or chemical induced diabetes mellitus with other circulatory complications
• E09.610 Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy
• E09.618 Drug or chemical induced diabetes mellitus with other diabetic arthropathy
• E09.620 Drug or chemical induced diabetes mellitus with diabetic dermatitis
• E09.621 Drug or chemical induced diabetes mellitus with foot ulcer
• E09.622 Drug or chemical induced diabetes mellitus with other skin ulcer
• E09.628 Drug or chemical induced diabetes mellitus with other skin complications
• E09.630 Drug or chemical induced diabetes mellitus with periodontal disease
• E09.638 Drug or chemical induced diabetes mellitus with other oral complications
• E09.641 Drug or chemical induced diabetes mellitus with hypoglycemia with coma
• E09.649 Drug or chemical induced diabetes mellitus with hypoglycemia without coma
• E09.65 Drug or chemical induced diabetes mellitus with hyperglycemia
• E09.69 Drug or chemical induced diabetes mellitus with other specified complication
• E09.8 Drug or chemical induced diabetes mellitus with unspecified complications
• E09.9 Drug or chemical induced diabetes mellitus without complications
• E10.10 Type 1 diabetes mellitus with ketoacidosis without coma
• E10.11 Type 1 diabetes mellitus with ketoacidosis with coma
• E10.21 Type 1 diabetes mellitus with diabetic nephropathy
• E10.22 Type 1 diabetes mellitus with diabetic chronic kidney disease
• E10.29 Type 1 diabetes mellitus with other diabetic kidney complication
• E10.311 Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema
• E10.319 Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema
• E10.3211 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
• E10.3212 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
• E10.3213 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
• E10.3219 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E10.3291 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
• E10.3292 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
• E10.3293 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
• E10.3299 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E10.3311 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
• E10.3312 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
• E10.3313 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
• E10.3319 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E10.3391 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
• E10.3392 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
• E10.3393 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
• E10.3399 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E10.3411 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
• E10.3412 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
• E10.3413 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
• E10.3419 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E10.3491 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
• E10.3492 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
• E10.3493 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
• E10.3499 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E10.3511 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
• E10.3512 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
• E10.3513 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
• E10.3519 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye
• E10.3521 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye
• E10.3522 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye
• E10.3523 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral
• E10.3529 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye
• E10.3531 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye
• E10.3532 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye
• E10.3533 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral
• E10.3539 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye
• E10.3541 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye
• E10.3542 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye
• E10.3543 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral
• E10.3549 Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye
• E10.3551 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, right eye
• E10.3552 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, left eye
• E10.3553 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral
• E10.3559 Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye
• E10.3591 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
• E10.3592 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
• E10.3593 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
• E10.3599 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye
• E10.36 Type 1 diabetes mellitus with diabetic cataract
• E10.37X1 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye
• E10.37X2 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye
• E10.37X3 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral
• E10.37X9 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye
• E10.39 Type 1 diabetes mellitus with other diabetic ophthalmic complication
• E10.40 Type 1 diabetes mellitus with diabetic neuropathy, unspecified
• E10.41 Type 1 diabetes mellitus with diabetic mononeuropathy
• E10.42 Type 1 diabetes mellitus with diabetic polyneuropathy
• E10.43 Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy
• E10.44 Type 1 diabetes mellitus with diabetic amyotrophy
• E10.49 Type 1 diabetes mellitus with other diabetic neurological complication
• E10.51 Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene
• E10.52 Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene
• E10.59 Type 1 diabetes mellitus with other circulatory complications
• E10.610 Type 1 diabetes mellitus with diabetic neuropathic arthropathy
• E10.618 Type 1 diabetes mellitus with other diabetic arthropathy
• E10.620 Type 1 diabetes mellitus with diabetic dermatitis
• E10.621 Type 1 diabetes mellitus with foot ulcer
• E10.622 Type 1 diabetes mellitus with other skin ulcer
• E10.628 Type 1 diabetes mellitus with other skin complications
• E10.630 Type 1 diabetes mellitus with periodontal disease
• E10.638 Type 1 diabetes mellitus with other oral complications
• E10.641 Type 1 diabetes mellitus with hypoglycemia with coma
• E10.649 Type 1 diabetes mellitus with hypoglycemia without coma
• E10.65 Type 1 diabetes mellitus with hyperglycemia
• E10.69 Type 1 diabetes mellitus with other specified complication
• E10.8 Type 1 diabetes mellitus with unspecified complications
• E10.9 Type 1 diabetes mellitus without complications
• E11.00 Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
• E11.01 Type 2 diabetes mellitus with hyperosmolarity with coma
• E11.21 Type 2 diabetes mellitus with diabetic nephropathy
• E11.22 Type 2 diabetes mellitus with diabetic chronic kidney disease
• E11.29 Type 2 diabetes mellitus with other diabetic kidney complication
• E11.311 Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema
• E11.319 Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema
• E11.3211 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
• E11.3212 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
• E11.3213 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
• E11.3219 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E11.3291 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
• E11.3292 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
• E11.3293 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
• E11.3299 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E11.3311 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
• E11.3312 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
• E11.3313 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
• E11.3319 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E11.3391 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
• E11.3392 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
• E11.3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
• E11.3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E11.3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
• E11.3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
• E11.3413 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
• E11.3419 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E11.3491 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
• E11.3492 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
• E11.3493 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
• E11.3499 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E11.3511 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
• E11.3512 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
• E11.3513 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
• E11.3519 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye
• E11.3521 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye
• E11.3522 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye
• E11.3523 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral
• E11.3529 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye
• E11.3531 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye
• E11.3532 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye
• E11.3533 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral
• E11.3539 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye
• E11.3541 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye
• E11.3542 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye
• E11.3543 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral
• E11.3549 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye
• E11.3551 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye
• E11.3552 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye
• E11.3553 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral
• E11.3559 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye
• E11.3591 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
• E11.3592 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
• E11.3593 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
• E11.3599 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye
• E11.36 Type 2 diabetes mellitus with diabetic cataract
• E11.37X1 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye
• E11.37X2 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye
• E11.37X3 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral
• E11.37X9 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye
• E11.39 Type 2 diabetes mellitus with other diabetic ophthalmic complication
• E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified
• E11.41 Type 2 diabetes mellitus with diabetic mononeuropathy
• E11.42 Type 2 diabetes mellitus with diabetic polyneuropathy
• E11.43 Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy
• E11.44 Type 2 diabetes mellitus with diabetic amyotrophy
• E11.49 Type 2 diabetes mellitus with other diabetic neurological complication
• E11.51 Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
• E11.52 Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene
• E11.59 Type 2 diabetes mellitus with other circulatory complications
• E11.610 Type 2 diabetes mellitus with diabetic neuropathic arthropathy
• E11.618 Type 2 diabetes mellitus with other diabetic arthropathy
• E11.620 Type 2 diabetes mellitus with diabetic dermatitis
• E11.621 Type 2 diabetes mellitus with foot ulcer
• E11.622 Type 2 diabetes mellitus with other skin ulcer
• E11.628 Type 2 diabetes mellitus with other skin complications
• E11.630 Type 2 diabetes mellitus with periodontal disease
• E11.638 Type 2 diabetes mellitus with other oral complications
• E11.641 Type 2 diabetes mellitus with hypoglycemia with coma
• E11.649 Type 2 diabetes mellitus with hypoglycemia without coma
• E11.65 Type 2 diabetes mellitus with hyperglycemia
• E11.69 Type 2 diabetes mellitus with other specified complication
• E11.8 Type 2 diabetes mellitus with unspecified complications
• E11.9 Type 2 diabetes mellitus without complications
• E13.00 Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
• E13.01 Other specified diabetes mellitus with hyperosmolarity with coma
• E13.10 Other specified diabetes mellitus with ketoacidosis without coma
• E13.11 Other specified diabetes mellitus with ketoacidosis with coma
• E13.21 Other specified diabetes mellitus with diabetic nephropathy
• E13.22 Other specified diabetes mellitus with diabetic chronic kidney disease
• E13.29 Other specified diabetes mellitus with other diabetic kidney complication
• E13.311 Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema
• E13.319 Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema
• E13.3211 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
• E13.3212 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
• E13.3213 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
• E13.3219 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E13.3291 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
• E13.3292 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
• E13.3293 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
• E13.3299 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E13.3311 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
• E13.3312 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
• E13.3313 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
• E13.3319 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E13.3391 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
• E13.3392 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
• E13.3393 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
• E13.3399 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E13.3411 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
• E13.3412 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
• E13.3413 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
• E13.3419 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye
• E13.3491 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
• E13.3492 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
• E13.3493 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
• E13.3499 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye
• E13.3511 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
• E13.3512 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
• E13.3513 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
• E13.3519 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye
• E13.3521 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye
• E13.3522 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye
• E13.3523 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral
• E13.3529 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye
• E13.3531 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye
• E13.3532 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye
• E13.3533 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral
• E13.3539 Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye
• E13.3541 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye
• E13.3542 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye
• E13.3543 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral
• E13.3549 Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye
• E13.3551 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye
• E13.3552 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye
• E13.3553 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral
• E13.3559 Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye
• E13.3591 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
• E13.3592 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
• E13.3593 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
• E13.3599 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye
• E13.36 Other specified diabetes mellitus with diabetic cataract
• E13.37X1 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, right eye
• E13.37X2 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, left eye
• E13.37X3 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral
• E13.37X9 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye
• E13.39 Other specified diabetes mellitus with other diabetic ophthalmic complication
• E13.40 Other specified diabetes mellitus with diabetic neuropathy, unspecified
• E13.41 Other specified diabetes mellitus with diabetic mononeuropathy
• E13.42 Other specified diabetes mellitus with diabetic polyneuropathy
• E13.43 Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy
• E13.44 Other specified diabetes mellitus with diabetic amyotrophy
• E13.49 Other specified diabetes mellitus with other diabetic neurological complication
• E13.51 Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene
• E13.52 Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene
• E13.59 Other specified diabetes mellitus with other circulatory complications
• E13.610 Other specified diabetes mellitus with diabetic neuropathic arthropathy
• E13.618 Other specified diabetes mellitus with other diabetic arthropathy
• E13.620 Other specified diabetes mellitus with diabetic dermatitis
• E13.621 Other specified diabetes mellitus with foot ulcer
• E13.622 Other specified diabetes mellitus with other skin ulcer
• E13.628 Other specified diabetes mellitus with other skin complications
• E13.630 Other specified diabetes mellitus with periodontal disease
• E13.638 Other specified diabetes mellitus with other oral complications
• E13.641 Other specified diabetes mellitus with hypoglycemia with coma
• E13.649 Other specified diabetes mellitus with hypoglycemia without coma
• E13.65 Other specified diabetes mellitus with hyperglycemia
• E13.69 Other specified diabetes mellitus with other specified complication
• E13.8 Other specified diabetes mellitus with unspecified complications
• E13.9 Other specified diabetes mellitus without complications
• R73.01 Impaired fasting glucose
• R73.02 Impaired glucose tolerance (oral)
• R73.03 Prediabetes
• R73.09 Other abnormal glucose
• R73.9 Hyperglycemia, unspecified
• Z13.1 Encounter for screening for diabetes mellitus
• Z83.3 Family history of diabetes mellitus
• Z86.32 Personal history of gestational diabetes

Frequency

• Initial year: Up to 10 hours of initial training within a continuous 12-month period
• Subsequent years: Up to 2 hours of follow-up training each year after the initial year

Medicare Beneficiary Pays

• Copayment/coinsurance applies
• Deductible applies

Alcohol Misuse Screening and Counseling CPT G0442 and G0443

HCPCS/CPT Codes

• G0442 – Annual alcohol misuse screening, 15 minutes
• G0443 – Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes

Who Is Covered

 

All Medicare beneficiaries are eligible for alcohol screening.

 

Medicare beneficiaries who screen positive (those who misuse alcohol but whose levels or patterns of alcohol consumption do not meet criteria for alcohol dependence) are eligible for counseling if,

• They are competent and alert at the time counseling is provided and
• Counseling is furnished by qualified primary care physicians or other primary care practitioners in a primary care setting

Covered ICD Codes

• F10.282 Alcohol dependence with alcohol-induced sleep disorder
• F10.288 Alcohol dependence with other alcohol-induced disorder
• F10.29 Alcohol dependence with unspecified alcohol-induced disorder
• F10.920 Alcohol use, unspecified with intoxication, uncomplicated
• F10.921 Alcohol use, unspecified with intoxication delirium
• F10.929 Alcohol use, unspecified with intoxication, unspecified
• F10.94 Alcohol use, unspecified with alcohol-induced mood disorder
• F10.950 Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions
• F10.951 Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations
• F10.959 Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified
• F10.96 Alcohol use, unspecified with alcohol-induced persisting amnestic disorder
• F10.97 Alcohol use, unspecified with alcohol-induced persisting dementia
• F10.980 Alcohol use, unspecified with alcohol-induced anxiety disorder
• F10.981 Alcohol use, unspecified with alcohol-induced sexual dysfunction
• F10.982 Alcohol use, unspecified with alcohol-induced sleep disorder
• F10.988 Alcohol use, unspecified with other alcohol-induced disorder
• F10.99 Alcohol use, unspecified with unspecified alcohol-induced disorder
• F12.23 Cannabis dependence with withdrawal
• F12.93 Cannabis use, unspecified with withdrawal
• O99.310 Alcohol use complicating pregnancy, unspecified trimester
• O99.311 Alcohol use complicating pregnancy, first trimester
• O99.312 Alcohol use complicating pregnancy, second trimester
• O99.313 Alcohol use complicating pregnancy, third trimester
• O99.314 Alcohol use complicating childbirth
• O99.315 Alcohol use complicating the puerperium
• R45.88 Nonsuicidal self-harm
• T51.8X2A Toxic effect of other alcohols, intentional self-harm, initial encounter
• T51.8X3A Toxic effect of other alcohols, assault, initial encounter
• T51.8X4A Toxic effect of other alcohols, undetermined, initial encounter
• T51.92XA Toxic effect of unspecified alcohol, intentional self-harm, initial encounter
• T51.93XA Toxic effect of unspecified alcohol, assault, initial encounter
• T51.94XA Toxic effect of unspecified alcohol, undetermined, initial encounter
• Z02.83 Encounter for blood-alcohol and blood-drug test
• Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
• Z13.31 Encounter for screening for depression
• Z13.32 Encounter for screening for maternal depression
• Z13.39 Encounter for screening examination for other mental health and behavioral disorders
• Z63.72 Alcoholism and drug addiction in family
• Z71.41 Alcohol abuse counseling and surveillance of alcoholic
• Z71.42 Counseling for family member of alcoholic
• Z71.84 Encounter for health counseling related to travel
• Z81.1 Family history of alcohol abuse and dependence

Frequency

• Annually for G0442
• For those who screen positive, 4 times per year for G0443

Medicare Beneficiary Pays

• Copayment/coinsurance waived
• Deductible waived

Influenza Virus Vaccine and Administration

 HCPCS/CPT Codes

• 90630 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use
• 90653 Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use
• 90654 Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use
• 90655 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use
• 90656 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use
• 90657 Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use
• 90658 Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use
• 90660 Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use
• 90661 Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use
• 90662 Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
• 90672 Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use
• 90673 Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
• 90674 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use
• 90685 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use
• 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
• 90687 Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
• 90688 Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
• Q2035 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Afluria)
• Q2036 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Flulaval)
• Q2037 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluvirin)
• Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluzone)
• Q2039 Influenza virus vaccine, not otherwise specified

Administration CPT Codes

• G0008  Administration of influenza virus vaccine
• 90471   Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)
• 90472  Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)
• 90460  Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered
• 90461 Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure)

ICD-10 Codes

• Z23

Who Is Covered

• All Medicare beneficiaries

Frequency

• Once per influenza season
• Medicare covers additional flu shots if medically necessary

Medicare Beneficiary Pays

• Copayment/coinsurance waived
• Deductible waived

List of CPT Codes for COVID-19

CPT Code CPT Code Description 

86318 Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip);

86328 Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])

86408 Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen

86409 Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer

86413 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative

86769 Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])

87301 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; adenovirus enteric types 40/41

87305 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Aspergillus

87320 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Chlamydia trachomatis

87324 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Clostridium difficile toxin(s)

87327 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Cryptococcus neoformans

87328 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; cryptosporidium

87329 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; giardia

87332 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; cytomegalovirus

87335 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Escherichia coli 0157

87336 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Entamoeba histolytica dispar group

87337 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Entamoeba histolytica group

87338 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Helicobacter pylori, stool

87339 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Helicobacter pylori

87340 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; hepatitis B surface antigen (HBsAg)

87341 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; hepatitis B surface antigen (HBsAg) neutralization

87350 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; hepatitis Be antigen (HBeAg)

87380 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; hepatitis, delta agent

87385 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Histoplasma capsulatum

87389 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result

87390 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; HIV-1

87391 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; HIV-2

87400 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Influenza, A or B, each

87420 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; respiratory syncytial virus

87425 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; rotavirus

87426 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])

87427 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Shiga-like toxin

87428 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B

87430 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Streptococcus, group A

87449 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; not otherwise specified, each organism

87451 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; polyvalent for multiple organisms, each polyvalent antiserum

87635 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique

87636 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique

87637 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique

87802 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group B

87803 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Clostridium difficile toxin A

87806 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies

87804 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza

87807 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; respiratory syncytial virus

87811 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])

87808 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Trichomonas vaginalis

87809 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; adenovirus

87810 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Chlamydia trachomatis

87850 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Neisseria gonorrhoeae

87880 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A

87899 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; not otherwise specified

0202U Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected

0223U Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected

0224U Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed

0225U Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected

0226U Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum

0240U Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 3 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B), upper respiratory specimen, each pathogen reported as detected or not detected

0241U Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected

99072 Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease

0001A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose

0002A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose

0003A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose

0004A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose

0051A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose

0052A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose

0053A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose

0054A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose

0071A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose

0072A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose

0011A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose

0012A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose

0013A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose

0064A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose

0021A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; first dose

0022A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; second dose

0031A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; single dose

0034A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; booster dose

0041A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; first dose

0042A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; second dose

91300 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use

91305 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use

91307 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use

91301 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage, for intramuscular use

91306 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use

91302 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage, for intramuscular use

91303 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage, for intramuscular use

91304 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage, for intramuscular use